BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36389781)

  • 1. Cryoablation and immune synergistic effect for lung cancer: A review.
    Tian Y; Qi X; Jiang X; Shang L; Xu K; Shao H
    Front Immunol; 2022; 13():950921. PubMed ID: 36389781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on the use of cryoablation and immunotherapy for breast cancer.
    Olagunju A; Forsman T; Ward RC
    Front Immunol; 2022; 13():1026475. PubMed ID: 36389815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the cryoablation and cryoimmunotherapy for tumor.
    Chen Z; Meng L; Zhang J; Zhang X
    Front Immunol; 2023; 14():1094009. PubMed ID: 36761748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological Aspects of Cryoablation of Non-Small Cell Lung Cancer: A Comprehensive Review.
    Katzman D; Wu S; Sterman DH
    J Thorac Oncol; 2018 May; 13(5):624-635. PubMed ID: 29391289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer.
    Lin M; Liang SZ; Wang XH; Liang YQ; Zhang MJ; Niu LZ; Chen JB; Li HB; Xu KC
    Immunol Res; 2017 Aug; 65(4):880-887. PubMed ID: 28508945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes.
    Takada M; Toi M
    Int J Clin Oncol; 2019 Jun; 24(6):608-613. PubMed ID: 30982153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryoablation and Immunotherapy: An Enthralling Synergy for Cancer Treatment.
    Medlej ZAA; Medlej W; Slaba S; Torrecillas P; Cueto A; Urbaneja A; Garrido AJ; Lugnani F
    Curr Oncol; 2023 May; 30(5):4844-4860. PubMed ID: 37232823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Local cryoablation combined with pembrolizumab to eliminate lung metastases from ovarian clear cell carcinoma.
    Meng L; Zhang Z; Zhang X; Zhang X; Wei Y; Wu B; Xue X; Zhang X; He X; Xiao Y
    Front Immunol; 2022; 13():1006500. PubMed ID: 36439155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryoablation and Immunotherapy for Breast Cancer: Overview and Rationale for Combined Therapy.
    Regen-Tuero HC; Ward RC; Sikov WM; Littrup PJ
    Radiol Imaging Cancer; 2021 Mar; 3(2):e200134. PubMed ID: 33817653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryoablation and immunity in non-small cell lung cancer: a new era of cryo-immunotherapy.
    Velez A; DeMaio A; Sterman D
    Front Immunol; 2023; 14():1203539. PubMed ID: 37671163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryoablation of early-stage primary lung cancer.
    Inoue M; Nakatsuka S; Jinzaki M
    Biomed Res Int; 2014; 2014():521691. PubMed ID: 24991559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen as prognostic factor for metastatic non-small cell lung cancer by percutaneous cryosurgery.
    Li H; Tang K; Niu L; Liang Y; Li J; Chen J; Xu K
    Cancer Biomark; 2013; 13(5):337-43. PubMed ID: 24440973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-guided conformal cryoablation for peripheral NSCLC: initial experience.
    Zhang X; Tian J; Zhao L; Wu B; Kacher DS; Ma X; Liu S; Ren C; Xiao YY
    Eur J Radiol; 2012 Nov; 81(11):3354-62. PubMed ID: 22626572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation.
    Kwak K; Yu B; Lewandowski RJ; Kim DH
    Theranostics; 2022; 12(5):2175-2204. PubMed ID: 35265206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Percutaneous Image-Guided Microwave Ablation and Cryoablation for Sarcoma Lung Metastases: A 10-Year Experience.
    Bourgouin PP; Wrobel MM; Mercaldo ND; Murphy MC; Leppelmann KS; Levesque VM; Muniappan A; Silverman SG; Shepard JO; Shyn PB; Fintelmann FJ
    AJR Am J Roentgenol; 2022 Mar; 218(3):494-504. PubMed ID: 34612679
    [No Abstract]   [Full Text] [Related]  

  • 16. Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer.
    Sardela de Miranda F; Castro M; Remmert N; Singh SP; Layeequr Rahman R; Melkus MW
    Front Immunol; 2023; 14():1258873. PubMed ID: 37860001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical efficacy of argon-helium knife cryoablation combined with nivolumab in the treatment of advanced non-small cell lung cancer.
    Feng J; Guiyu D; Xiongwen W
    Cryobiology; 2021 Oct; 102():92-96. PubMed ID: 34302805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular Carcinoma.
    Li X; Xu J; Gu X; Chen L; Wu Q; Li H; Bai H; Yang J; Qian J
    Front Immunol; 2021; 12():740790. PubMed ID: 34733279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complications of cryoablation in 644 lung cancer patients and its treatment].
    Niu L; Wang J; Zhou L; Wu B; Mu F; Li H; Hu Y; Hu Y; Zuo J; Xu K
    Zhongguo Fei Ai Za Zhi; 2010 Aug; 13(8):832-4. PubMed ID: 20704828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?
    Sainani NI; Shyn PB; Tatli S; Morrison PR; Tuncali K; Silverman SG
    J Vasc Interv Radiol; 2011 Mar; 22(3):354-60. PubMed ID: 21353987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.